Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 24 min ago
Peer-reviewedCC BYPharmaceutics

Microbiota–Gut–Brain Axis Interactions with CNS Drugs: A Critical Mechanistic Review of Biopharmaceutical, Pharmacokinetic, and Pharmacodynamic Evidence

Read full textPDFCite

Related

  1. Phytocannabinoid-drug interactions: pharmacokinetic and pharmacodynamic mechanisms, clinical relevance and toxicological considerations
    Diogo Alexandre Gomes, Wellyngton Vieira Eufrázio, Marcella Silva Ribeiro +6
    Frontiers in toxicologyPeer-reviewedCC BYFull textEurope PMC
  2. Preclinical Pharmacokinetic‐Pharmacodynamic Modeling of Antibody Nanoconjugates for Breast Cancer Treatment
    Anne Rodallec, Cristina Vaghi, Joseph Ciccolini +2
    CPT: pharmacometrics & systems pharmacologyPeer-reviewedCC BY-NC-NDFull textEurope PMC
  3. Caenorhabditis elegans as a Model to Dissect Pharmacokinetic and Pharmacodynamic Relationships of Gabapentinoids
    J. Sultana, J. D. Castano, J. R. E. del Castillo +1
    bioRxivPreprintAll rights reservedFull textPharmacology & toxicologybioRxiv
  4. Optimized Flomoxef Dosing Strategy for Extended-Spectrum Beta-Lactamase-Producing Bacteria, Based on Pooled Pharmacokinetic and Pharmacodynamic Analysis
    Tetsushu Onita, Yui Sano, Nami Kuruma +5
    PharmaceuticsPeer-reviewedCC BYFull textEurope PMC
  5. Integrated Structural, Physicochemical, Pharmacokinetic and Pharmacodynamic Evaluation of Substituted Phenylcarbonyloxypiperazinopropanols as Antimycobacterial Agents
    Dominika Nádaská, Tomáš Sádecký, Lucia Račková +7
    Life (Basel, Switzerland)Peer-reviewedCC BYFull textEurope PMC

Cite

BibTeXRIS
BibTeX
@article{anon2026microbiotagutbrain,
  title = {{Microbiota–Gut–Brain Axis Interactions with CNS Drugs: A Critical Mechanistic Review of Biopharmaceutical, Pharmacokinetic, and Pharmacodynamic Evidence}},
  journal = {Pharmaceutics},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13708323},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Microbiota–Gut–Brain Axis Interactions with CNS Drugs: A Critical Mechanistic Review of Biopharmaceutical, Pharmacokinetic, and Pharmacodynamic Evidence
PY  - 2026
DA  - 2026/10/01
JO  - Pharmaceutics
UR  - https://europepmc.org/article/PMC/PMC13708323
SN  - 1999-4923
ER  -